Edition:
United Kingdom

Valneva SE (VLS.PA)

VLS.PA on Paris Stock Exchange

3.83EUR
18 Sep 2018
Change (% chg)

€0.03 (+0.79%)
Prev Close
€3.80
Open
€3.77
Day's High
€3.84
Day's Low
€3.74
Volume
71,536
Avg. Vol
96,263
52-wk High
€4.19
52-wk Low
€2.64

Select another date:

Thu, Mar 22 2018

BRIEF-Valneva FY Net Loss Narrows To 11.5 Million Euros

* EXPECTS DOUBLE-DIGIT PRODUCT SALES GROWTH TO CONTINUE IN 2018

BRIEF-Valneva Says No Safety Concerns Associated With VLA15 In Any Treatment Group‍​

* NO SAFETY CONCERNS ASSOCIATED WITH VLA15 IN ANY TREATMENT GROUP‍​

BRIEF-Valneva Reports Positive Phase I Interim Results For Its Lyme Vaccine Candidate VLA15

* VALNEVA REPORTS POSITIVE PHASE I INTERIM RESULTS FOR ITS LYME VACCINE CANDIDATE VLA15 Source text for Eikon: Further company coverage: (Reuters.Brief@thomsonreuters.com)

BRIEF-Valneva Reports Positive Phase I Interim Results For Its Lyme Vaccine Candidate Vla15

* REG-VALNEVA REPORTS POSITIVE PHASE I INTERIM RESULTS FOR ITS LYME VACCINE CANDIDATE VLA15

Select another date: